SIC
IRWD icon

SJS Investment Consulting’s Ironwood Pharmaceuticals IRWD Stock Holding History

SJS Investment Consulting’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
388
+83
+27% +$320 ﹤0.01% 1853
2026
Q1 		$1.07K Buy
305
+284
+1,352% +$1.16K ﹤0.01% 1439
2025
Q4 		$71 Buy
+21
New +$55 ﹤0.01% 1987
2024
Q3 		– Sell
-5
Closed -$33 – 1684
2024
Q2 		$33 Sell
5
-20
-80% -$141 ﹤0.01% 1638
2024
Q1 		$218 Hold
25
– – ﹤0.01% 1469
2023
Q4 		$286 Buy
25
+1
+4% +$10 ﹤0.01% 1390
2023
Q3 		$232 Sell
24
-1
-4% -$10 ﹤0.01% 1430
2023
Q2 		$266 Sell
25
-8
-24% -$86 ﹤0.01% 1347
2023
Q1 		$348 Buy
33
+4
+14% +$45 ﹤0.01% 1252
2022
Q4 		$359 Sell
29
-23
-44% -$261 ﹤0.01% 1302
2022
Q3 		$0 Buy
+52
New +$590 ﹤0.01% 1275
2022
Q1 		$0 Buy
+4
New +$46 ﹤0.01% 1019

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SJS Investment Consulting's IRWD Position: Q2 2026 in Review

SJS Investment Consulting increased its Ironwood Pharmaceuticals (IRWD) stake by 27% in Q2 2026, buying an estimated $320 and bringing the position to 388 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

SJS Investment Consulting first reported a position in IRWD in Q1 2022 and has held it in 12 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • SJS Investment Consulting held 388 shares of Ironwood Pharmaceuticals worth $1.63K as of Q2 2026.
  • SJS Investment Consulting bought 83 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $320.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1853 holding.
  • SJS Investment Consulting first reported a position in Ironwood Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.